AJOONI vs REGAAL: Stock Comparison

Ajooni Biotech Limited vs Regaal Resources Limited

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Regaal Resources Limited is the larger company by market capitalisation. Ajooni Biotech Limited shows faster revenue growth, lower leverage and a higher ROCE, while Regaal Resources Limited shows a higher ROE and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Ajooni Biotech Limited and Regaal Resources Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, AJOONI is more favourable on 4 of 9 scored metrics and REGAAL on 4These counts are context-free and are not an overall rating.

Key Differences

Market Cap
REGAAL is the larger company
₹791 Cr vs ₹70 Cr
EPS
AJOONI has higher earnings per share
₹0.25 vs ₹0
Revenue Growth (TTM YoY)
AJOONI has faster revenue growth
103.3% vs 0%
EPS Growth (TTM YoY)
REGAAL has faster EPS growth
0% vs -44.4%
ROE
REGAAL has a higher ROE
11.35% vs 4.82%
ROCE
AJOONI has a higher ROCE
6.49% vs 0%
Net Margin
REGAAL has a higher net margin
4.9% vs 2.34%
Operating Margin
REGAAL has a higher operating margin
9.29% vs 3.43%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricAJOONIREGAAL
SectorFast Moving Consumer GoodsFast Moving Consumer Goods
IndustryAnimal FeedOther Agricultural Products

Price

MetricAJOONIREGAAL
Live Price₹4.03₹85.92
Day Change2.03%-11.56%
Volume6.6 L12.31 L
52-Week High₹5.94₹145.7
52-Week Low₹3.4₹57.27
Distance from 52W High-32.15%-41.03%

Valuation

MetricAJOONIREGAAL
Market Cap₹70 Cr₹791 Cr
P/E Ratio14.43x
P/B Ratio1.64x
EPS₹0.25₹0
Book Value₹4.81₹0
Dividend Yield0%0%

Growth

MetricAJOONIREGAAL
Revenue Growth (TTM YoY)103.3%0%
EPS Growth (TTM YoY)-44.4%0%
Qtr Sales Growth107%
Qtr Profit Growth-38.3%

Profitability & Leverage

MetricAJOONIREGAAL
ROE4.82%11.35%
ROCE6.49%0%
Net Margin2.34%4.9%
Operating Margin3.43%9.29%
Debt to Equity0.19x1.25x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricAJOONIREGAAL
Promoter Holding26.89%71.32%
FII Holding0%0.31% 0.03 pp
DII Holding0%2.58% 0.24 pp
Public Holding73.11%25.79% 0.27 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Ajooni Biotech Limited and Regaal Resources Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.